BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 21924289)

  • 1. Metformin and neoplasia: implications and indications.
    Aljada A; Mousa SA
    Pharmacol Ther; 2012 Jan; 133(1):108-15. PubMed ID: 21924289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic roles of AMPK and metformin in cancer cells.
    Choi YK; Park KG
    Mol Cells; 2013 Oct; 36(4):279-87. PubMed ID: 23794020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin and cancer immunity.
    Ma R; Yi B; Riker AI; Xi Y
    Acta Pharmacol Sin; 2020 Nov; 41(11):1403-1409. PubMed ID: 32868904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of polo-like kinase 1 (Plk1) enhances the antineoplastic activity of metformin in prostate cancer.
    Shao C; Ahmad N; Hodges K; Kuang S; Ratliff T; Liu X
    J Biol Chem; 2015 Jan; 290(4):2024-33. PubMed ID: 25505174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colorectal and Prostate Cancer Risk in Diabetes: Metformin, an Actor behind the Scene.
    Anwar MA; Kheir WA; Eid S; Fares J; Liu X; Eid AH; Eid AA
    J Cancer; 2014; 5(9):736-44. PubMed ID: 25368673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin inhibits epithelial-mesenchymal transition in prostate cancer cells: involvement of the tumor suppressor miR30a and its target gene SOX4.
    Zhang J; Shen C; Wang L; Ma Q; Xia P; Qi M; Yang M; Han B
    Biochem Biophys Res Commun; 2014 Sep; 452(3):746-52. PubMed ID: 25201727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin and cancer.
    Vallianou NG; Evangelopoulos A; Kazazis C
    Rev Diabet Stud; 2013; 10(4):228-35. PubMed ID: 24841876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin: a metabolic disruptor and anti-diabetic drug to target human leukemia.
    Rosilio C; Ben-Sahra I; Bost F; Peyron JF
    Cancer Lett; 2014 May; 346(2):188-96. PubMed ID: 24462823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-cancer Effects of Metformin: Recent Evidences for its Role in Prevention and Treatment of Cancer.
    Kheirandish M; Mahboobi H; Yazdanparast M; Kamal W; Kamal MA
    Curr Drug Metab; 2018; 19(9):793-797. PubMed ID: 29663879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin as an adjuvant treatment for cancer: a systematic review and meta-analysis.
    Coyle C; Cafferty FH; Vale C; Langley RE
    Ann Oncol; 2016 Dec; 27(12):2184-2195. PubMed ID: 27681864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticarcinogenic Effects of Gold Nanoparticles and Metformin Against MCF-7 and A549 Cells.
    Yeşildağ A; Kızıloğlu HT; Dirican E; Erbaş E; Gelen V; Kara A
    Biol Trace Elem Res; 2024 Feb; ():. PubMed ID: 38358644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel action of insulin sensitizing drug as a potential promotor of preovulatory follicles, ovulation rate and prolificacy in sheep.
    Kumawat BL; Kumar P; Mahla AS; Kumar A; Kumar A; Singh R; Kumar A
    Vet Res Commun; 2024 Apr; 48(2):849-863. PubMed ID: 37957451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes, metformin use, and survival in esophageal cancer: a population-based cohort study.
    Wang QL; Santoni G; Lagergren J
    JNCI Cancer Spectr; 2023 Jul; 7(4):. PubMed ID: 37314979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Applications of Metformin in Dentistry-A review.
    Hammad Uddin MK; Khan Sadiq MS; Ahmed A; Khan M; Maniar T; Mateen SM; Saba B; Kashif SM; Usman S; Najeeb S; Khurshid Z; Zafar MS
    J Taibah Univ Med Sci; 2023 Dec; 18(6):1299-1310. PubMed ID: 37275952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent Advances (2015-2020) in Drug Discovery for Attenuation of Pulmonary Fibrosis and COPD.
    Dorababu A; Maraswami M
    Molecules; 2023 Apr; 28(9):. PubMed ID: 37175084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating selenoprotein P levels predict glucose-lowering and insulinotropic effects of metformin, but not alogliptin: A post-hoc analysis.
    Takeshita Y; Tanaka T; Takayama H; Kita Y; Goto H; Nakano Y; Saito Y; Takamura T
    J Diabetes Investig; 2023 Feb; 14(2):230-235. PubMed ID: 36479595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo and in vitro studies evaluating the chemopreventive effect of metformin on the aryl hydrocarbon receptor-mediated breast carcinogenesis.
    Alhoshani A; Alotaibi M; As Sobeai HM; Alharbi N; Alhazzani K; Al-Dhfyan A; Alanazi FE; Korashy HM
    Saudi J Biol Sci; 2021 Dec; 28(12):7396-7403. PubMed ID: 34867043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiogenesis Pathway in Kidney Renal Clear Cell Carcinoma and Its Prognostic Value for Cancer Risk Prediction.
    Che X; Su W; Li X; Liu N; Wang Q; Wu G
    Front Med (Lausanne); 2021; 8():731214. PubMed ID: 34778292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin-loaded lecithin nanoparticles induce colorectal cancer cytotoxicity via epigenetic modulation of noncoding RNAs.
    Abd-Rabou AA; Abdelaziz AM; Shaker OG; Ayeldeen G
    Mol Biol Rep; 2021 Oct; 48(10):6805-6820. PubMed ID: 34468912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations of aspirin, statins and metformin with lung cancer risk and related mortality.
    Frille A; Costantini A; Sreter KB
    Breathe (Sheff); 2021 Jun; 17(2):200325. PubMed ID: 34295419
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.